Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer.

Nakamura, Ryohta; Hasegawa, Go; Ohashi, Kazumasa; Hashimoto, Takehisa; Ikeda, Yohei; Hara, Noboru; Nishiyama, Tsutomu

Nakamura, Ryohta; Hasegawa, Go; Ohashi, Kazumasa; Hashimoto, Takehisa; Ikeda, Yohei; Hara, Noboru; Nishiyama, Tsutomu.

Afiliação

Nakamura R; Department of Urology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.
Hasegawa G; Department of Pathology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.
Ohashi K; Department of Respiratory Medicine, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.
Hashimoto T; Department of Respiratory Surgery, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.
Ikeda Y; Department of Diagnostic Radiology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.
Hara N; Department of Urology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.
Nishiyama T; Department of Urology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata Japan.

IJU Case Rep ; 6(1): 85-88, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36605695